Clement Chung

1.4k total citations
49 papers, 955 citations indexed

About

Clement Chung is a scholar working on Oncology, Molecular Biology and Artificial Intelligence. According to data from OpenAlex, Clement Chung has authored 49 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Artificial Intelligence. Recurrent topics in Clement Chung's work include Topic Modeling (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Clement Chung is often cited by papers focused on Topic Modeling (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Clement Chung collaborates with scholars based in United States, Canada and Ireland. Clement Chung's co-authors include Andrew Emili, Brendan J. Frey, Alexandr Ignatchenko, Quaid Morris, Anthony O. Gramolini, Anitha Kannan, Pingzhao Hu, Brian Cox, Thomas Kislinger and Janet Rossant and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Clement Chung

45 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clement Chung United States 14 515 238 168 82 72 49 955
Emmanuel Petricoin United States 11 597 1.2× 325 1.4× 146 0.9× 146 1.8× 74 1.0× 19 871
Brian Piening United States 17 720 1.4× 321 1.3× 375 2.2× 127 1.5× 69 1.0× 59 1.5k
Stella Somiari United States 17 722 1.4× 217 0.9× 237 1.4× 390 4.8× 93 1.3× 28 1.4k
Qing Zhong China 19 503 1.0× 69 0.3× 103 0.6× 222 2.7× 149 2.1× 77 970
Gökhan Ertaylan Belgium 16 396 0.8× 115 0.5× 263 1.6× 155 1.9× 32 0.4× 39 837
Fabian Coscia Germany 17 1.1k 2.2× 391 1.6× 332 2.0× 266 3.2× 127 1.8× 29 1.7k
Nicholas W. Bateman United States 21 837 1.6× 378 1.6× 246 1.5× 222 2.7× 96 1.3× 69 1.4k
Stephan Aiche Germany 8 758 1.5× 452 1.9× 89 0.5× 41 0.5× 35 0.5× 10 1.0k
Jana Fischer Germany 9 791 1.5× 74 0.3× 354 2.1× 213 2.6× 56 0.8× 13 1.2k
Yi Zhu China 22 609 1.2× 201 0.8× 125 0.7× 271 3.3× 343 4.8× 75 1.2k

Countries citing papers authored by Clement Chung

Since Specialization
Citations

This map shows the geographic impact of Clement Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clement Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clement Chung more than expected).

Fields of papers citing papers by Clement Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clement Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clement Chung. The network helps show where Clement Chung may publish in the future.

Co-authorship network of co-authors of Clement Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Clement Chung. A scholar is included among the top collaborators of Clement Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clement Chung. Clement Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Clement, et al.. (2025). Rising with cardio-oncology: Clinical considerations of cardiotoxicity with select anticancer drug therapies. American Journal of Health-System Pharmacy.
2.
Chung, Clement. (2025). Therapeutic advances in chronic lymphocytic leukemia: A focus on molecular pathogenesis, targeted therapies, and supportive care. American Journal of Health-System Pharmacy. 82(16). 868–885. 1 indexed citations
4.
Dupuy, Christophe, et al.. (2023). Coordinated Replay Sample Selection for Continual Federated Learning. 331–342. 1 indexed citations
6.
Chung, Clement. (2022). A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?. SHILAP Revista de lepidopterología. Volume 12. 99–106. 4 indexed citations
7.
Passban, Peyman, et al.. (2022). Training Mixed-Domain Translation Models via Federated Learning. Proceedings of the 2022 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies. 2576–2586. 7 indexed citations
8.
Chung, Clement, et al.. (2022). Paraneoplastic syndromes: A focus on pathophysiology and supportive care. American Journal of Health-System Pharmacy. 79(22). 1988–2000. 2 indexed citations
9.
Chung, Clement. (2018). Restoring the switch for cancer cell death: Targeting the apoptosis signaling pathway. American Journal of Health-System Pharmacy. 75(13). 945–952. 28 indexed citations
10.
Chung, Clement. (2016). Management of neuroendocrine tumors. American Journal of Health-System Pharmacy. 73(21). 1729–1744. 12 indexed citations
12.
Chung, Clement, et al.. (2014). Trametinib: A novel signal transduction inhibitor for the treatment of metastatic cutaneous melanoma. American Journal of Health-System Pharmacy. 72(2). 101–110. 11 indexed citations
13.
Chung, Clement, et al.. (2014). Neoadjuvant Chemotherapeutic and Targeted Therapies for Early-stage, High-risk Breast Cancer. European Oncology & Haematology. 10(1). 28–28. 1 indexed citations
14.
Chung, Clement, et al.. (2013). Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer. American Journal of Health-System Pharmacy. 70(18). 1579–1587. 13 indexed citations
15.
Chung, Clement & Matthew D. Christianson. (2013). Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation. Journal of Oncology Pharmacy Practice. 20(1). 11–28. 47 indexed citations
16.
Chung, Clement, et al.. (2013). Ziv-aflibercept: A novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer. American Journal of Health-System Pharmacy. 70(21). 1887–1896. 27 indexed citations
17.
Chung, Clement, et al.. (2011). Development and implementation of an interdisciplinary oncology program in a community hospital. American Journal of Health-System Pharmacy. 68(18). 1740–1747. 23 indexed citations
18.
19.
Kislinger, Thomas, Brian Cox, Anitha Kannan, et al.. (2006). Global Survey of Organ and Organelle Protein Expression in Mouse: Combined Proteomic and Transcriptomic Profiling. Cell. 125(1). 173–186. 377 indexed citations
20.
Maziarz, Marlena, Clement Chung, Daniel J. Drucker, & Andrew Emili. (2005). Integrating Global Proteomic and Genomic Expression Profiles Generated from Islet α Cells. Molecular & Cellular Proteomics. 4(4). 458–474. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026